Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates
- PMID: 8603960
- DOI: 10.1093/infdis/173.4.829
Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates
Abstract
Optimal immunization of neonates against disease caused by respiratory syncytial virus (RSV) probably will require multiple doses of a vaccine containing viruses of both subgroups A and B. Live subgroup B RSV mutants were generated containing multiple attenuating mutations, ts (temperature-sensitive) and non-ts (host range), that were introduced by prolonged passage in cell culture or by chemical mutagenesis. The cold-passaged (cp)-52 mutant was restricted in replication compared to wild type virus in rodents and nonhuman primates. In addition, the attenuation phenotype of cp-52 was stable after prolonged replication in immunosuppressed rodents. One or two ts mutations were then introduced into the cp-52 mutant to generate additional candidate vaccine strains that were more attenuated in vivo than the cp-52 parental virus. Tests in humans are being done to determine if one or more of the RSV B-1 mutants exhibit a satisfactory balance between attenuation and immunogenicity.
Similar articles
-
Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis.Vaccine. 1994 Jun;12(8):691-9. doi: 10.1016/0264-410x(94)90218-6. Vaccine. 1994. PMID: 8091846
-
A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees.Vaccine. 1994 Jul;12(9):783-90. doi: 10.1016/0264-410x(94)90286-0. Vaccine. 1994. PMID: 7975856
-
Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization.Vaccine. 1995 Jun;13(9):847-55. doi: 10.1016/0264-410x(94)00074-w. Vaccine. 1995. PMID: 7483808
-
Respiratory syncytial virus vaccine development.Curr Opin Pediatr. 2000 Jun;12(3):257-62. doi: 10.1097/00008480-200006000-00015. Curr Opin Pediatr. 2000. PMID: 10836163 Review.
-
Respiratory syncytial virus vaccines.Clin Microbiol Rev. 1998 Jul;11(3):430-9. doi: 10.1128/CMR.11.3.430. Clin Microbiol Rev. 1998. PMID: 9665976 Free PMC article. Review.
Cited by
-
Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level.Emerg Infect Dis. 2021 Jun;27(6):1-9. doi: 10.3201/eid2706.204608. Emerg Infect Dis. 2021. PMID: 34013862 Free PMC article.
-
Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice.J Virol. 1999 Sep;73(9):7099-107. doi: 10.1128/JVI.73.9.7099-7107.1999. J Virol. 1999. PMID: 10438795 Free PMC article.
-
Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates.J Virol. 1999 Dec;73(12):9773-80. doi: 10.1128/JVI.73.12.9773-9780.1999. J Virol. 1999. PMID: 10559287 Free PMC article.
-
RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G.J Virol. 2004 May;78(10):5015-22. doi: 10.1128/jvi.78.10.5015-5022.2004. J Virol. 2004. PMID: 15113882 Free PMC article.
-
Cross-protective antibodies against common endemic respiratory viruses.Nat Commun. 2023 Feb 13;14(1):798. doi: 10.1038/s41467-023-36459-3. Nat Commun. 2023. PMID: 36781872 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous